Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis.
about
Drug-induced uveitisAdalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study.Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis.[Differential diagnosis of anterior uveitis].
P2860
Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis.
@ast
Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis.
@en
type
label
Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis.
@ast
Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis.
@en
prefLabel
Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis.
@ast
Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis.
@en
P2093
P2860
P356
P1476
Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis.
@en
P2093
Antoine P Brézin
Dominique Monnet
Laurence Moachon
P2860
P304
P356
10.1038/NCPRHEUM0225
P577
2006-07-01T00:00:00Z